Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients

Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19* / prevention & control
  • Hematologic Neoplasms* / therapy
  • Humans
  • Immunity, Cellular
  • Immunity, Humoral
  • SARS-CoV-2
  • Vaccination
  • Vaccines*

Substances

  • Vaccines
  • Antibodies, Viral